Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

SMC May Update

The Scottish Medicines Consortium has issued its monthly advice on new medicines.

Aliskiren (Rasilez®) has been rejected for the treatment of essential hypertension. Escitalopram (Cipralex®) has been rejected for the treatment of social anxiety disorder. Both rejections we made because the manufacturers failed to make a submission.

Action: Clinicians should be aware of the recommendations of the SMC. Routine use of rejected medicines should be avoided.

Share 'SMC May Update' on Email Share 'SMC May Update' on Delicious Share 'SMC May Update' on Digg Share 'SMC May Update' on Facebook Share 'SMC May Update' on Google+ Share 'SMC May Update' on reddit Share 'SMC May Update' on StumbleUpon Share 'SMC May Update' on Twitter

atomic-wealth

No Comments to “SMC May Update”

Leave a Comment

(required)

(required)


Prescribing Advice for GPs is powered by WordPress.
Subscribe for Free to our RSS or Atom Feeds for New Entries.
Akismet has protected Prescribing Advice for GPs from 789,431 spam comments.

atomic-wealth
fond-illness
summer